Epigallocatechin-3-gallate rapidly remodels PAP85-120, SEM1(45-107), and SEM2(49-107) seminal amyloid fibrils

Biology Open
Laura M CastellanoJames Shorter

Abstract

Semen harbors amyloid fibrils formed by proteolytic fragments of prostatic acid phosphatase (PAP248-286 and PAP85-120) and semenogelins (SEM1 and SEM2) that potently enhance HIV infectivity. Amyloid but not soluble forms of these peptides enhance HIV infection. Thus, agents that remodel these amyloid fibrils could prevent HIV transmission. Here, we confirm that the green tea polyphenol, epigallocatechin-3-gallate (EGCG), slowly remodels fibrils formed by PAP248-286 termed SEVI (semen derived enhancer of viral infection) and also exerts a direct anti-viral effect. We elucidate for the first time that EGCG remodels PAP85-120, SEM1(45-107), and SEM2(49-107) fibrils more rapidly than SEVI fibrils. We establish EGCG as the first small molecule that can remodel all four classes of seminal amyloid. The combined anti-amyloid and anti-viral properties of EGCG could have utility in preventing HIV transmission.

References

Jan 25, 2002·Annual Review of Pharmacology and Toxicology·Chung S YangXiaofeng Meng
Nov 12, 2003·The Journal of Allergy and Clinical Immunology·Christina L Nance, William T Shearer
Nov 12, 2003·The Journal of Allergy and Clinical Immunology·Kazushige KawaiHirokazu Nagawa
Oct 19, 2004·Proceedings of the National Academy of Sciences of the United States of America·Catherine M FinneganRobert Blumenthal
Oct 13, 2005·Journal of the American Chemical Society·Michael FokkensFrank-Gerrit Klärner
Apr 4, 2006·Journal of the American College of Nutrition·Carmen CabreraRafael Giménez
Dec 18, 2007·Cell·Jan MünchFrank Kirchhoff
Dec 22, 2007·Neuro-Signals·James Shorter
May 16, 2008·Proceedings of the National Academy of Sciences of the United States of America·Huan WangJames Shorter
May 31, 2008·Nature Structural & Molecular Biology·Dagmar E EhrnhoeferErich E Wanker
Jun 5, 2008·Nature Structural & Molecular Biology·Blake E Roberts, James Shorter
Oct 1, 2008·Experimental Diabetes Research·Gunilla T Westermark, Per Westermark
Feb 11, 2009·The Journal of Allergy and Clinical Immunology·Christina L NanceWilliam T Shearer
May 20, 2009·Proceedings of the National Academy of Sciences of the United States of America·Ilona HauberJoachim Hauber
Nov 17, 2009·Nature Chemical Biology·Blake E RobertsJames Shorter
Apr 14, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jan BieschkeErich E Wanker
Apr 28, 2010·Molecular BioSystems·James Shorter
Sep 14, 2010·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Fan JiangYali Zhao
Oct 12, 2010·Prion·Martin L Duennwald, James Shorter
Jul 7, 2011·Antiviral Chemistry & Chemotherapy·Shenwei LiEiichi N Kodama
Jul 26, 2011·Archives of Biochemistry and Biophysics·Indu R ChandrashekaranRaymond S Norton
Aug 30, 2011·Nature Chemical Biology·Lucy A WoodsSheena E Radford
Mar 1, 2012·The Journal of Physical Chemistry. B·Nataliya PopovychAyyalusamy Ramamoorthy
Oct 18, 2012·British Journal of Pharmacology·J SteinmannE Steinmann
Apr 25, 2013·Journal of the American Chemical Society·Fernando L PalhanoJeffery W Kelly
Jan 21, 2014·Cell·Meredith E JackrelJames Shorter
Apr 3, 2014·Nature Communications·Shariq M UsmaniJan Münch
Jan 1, 2012·Biology·Laura M Castellano, James Shorter
Jun 21, 2015·Advances in Experimental Medicine and Biology·Kathrin Andrich, Jan Bieschke
Aug 11, 2015·Chemistry & Biology·Laura M CastellanoJames Shorter

❮ Previous
Next ❯

Citations

Dec 25, 2015·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·Hiroyuki NakajimaNaomi Sakashita
Nov 27, 2015·Journal of Molecular Biology·Elizabeth A Sweeny, James Shorter
Mar 2, 2018·Protein Science : a Publication of the Protein Society·Young-Ho Lee, Ayyalusamy Ramamoorthy
Jun 7, 2018·Chemical Communications : Chem Comm·Annika RöckerJan Münch
Sep 29, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Kunihiro KaihatsuYasuhito Ebara
Mar 23, 2017·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Run-Hong ZhouJie-Liang Li
Apr 15, 2018·Journal of Cell Science·Edward ChuangJames Shorter
May 27, 2016·The Journal of Biological Chemistry·Josephine G LoRiccoGeorge I Makhatadze
Jul 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ying-Qi WangYue-Rong Liang
Aug 16, 2017·Accounts of Chemical Research·Daniel A SheikJerry Yang

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.